LE WE PMID CA
Amyotrophic lateral sclerosis136Amyotrophe Lateralsklerose

ADAR2

ADTB3A

ALS2 Alsin

Alzheimer s disease

Amyotrophic lateral sclerosis slow progressing ALS8

Amyotrophic lateral sclerosis

Angiogenin

ARC syndrome

ARL6

Bardet Biedl syndrome

beta Actin

beta3 spectrin

CEDNIK syndrome

Cell secretion (Intracellular transport)

Changes in terminology

Charcot Marie Tooth disease type 2a

Charcot Marie Tooth disease type 2b

Chediak Higashi syndrome

Choroideremia

CNS (Astrocyte)

COG7

Congenital disorder of glycosylation type IIe

Cranio lenticulo sutural dysplasia

CYFIP2

Deafness (Inherited)

Developmental malformations deafness dystonia OMIM_607371

DTNBP1

Dysferlin

Elajalde syndrome Griscelli syndrome II

Epilepsy (Excitotoxicity)

ERS UFR (Diseases)

Factor V (Coagulation)

Factor VIII (Coagulation)

Familial hemophagoctic lymphohistiocytosis

Frontotemporal lobar degeneration

FUS TLS

GluR2

Griscelli s syndrome III

Griscelli s syndrome2

GSK3

Guam Parkinson dementia complex

Hereditary spastic paraplegia SPG10

Hereditary spastic paraplegia SPG4

Hermansky Pudlak syndrome

HPS1

HPS3

HPS4

HPS5

HPS6

KIF1B

KIF5A

Limb girdle muscular dystrophy type 2B

LMAN1 ERGIC53

Lowe s syndrome

LYST CHS1

Martsolf syndrome

MCFD2

Mitochondria (BASKET)

Mitochondria (Dysfunction)

Mitochondria (Permeability transition)

Miyoshi s myopathy

MLPH

Myosin Ia Myo1a

Myosin Va Myo5a

Myosin VI

Myosin VIIa

Myosin XVa Myo15a

OCRL1

OMIM_300104

Protein (ptm S nitrosylation)

Protein disulfide isomerase

RAB27A

RAB3GAP

RAB7

RABGDIA

REP1

RNA (Binding proteins)

RNA (Editing)

SEC23A

Selen

SNAP29

SPG20 Spartin

SPG4 Spastin

Spinal muscular atrophy late onset

Spinocerebellar ataxia5

Superoxide dismutase SOD

Syntaxin11

TDP43

Threohydroxyaspartate

trans 1 2 bis mercaptoacetamido cyclohexane ttPDI mimic

Troyer syndrome SPG20

UNC13D Munc13 4 HPLH3

Usher syndrome type Ib

VAPB

VPS33B

Warburg Micro syndrome

2006  
1
Amyotrophic lateral sclerosis: update for family physicians.
[17279237] Can Fam Physician 52(12): 1563-9 (2006)
2006  
2
ALS: a disease of motor neurons and their nonneuronal neighbors.
[17015226] Neuron 52(1): 39-59 (2006)
1999  
3
From Charcot to SOD1: mechanisms of selective motor neuron death in ALS.
[10595505] Neuron 24(3): 515-20 (1999)
2001  
4
Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded.
[11239414] Cell 104(4): 581-91 (2001)
2004  
5
Complex genetics of amyotrophic lateral sclerosis.
[15478096] Am J Hum Genet 75(6): 933-47 (2004)
2008  
6
Amyotrophic lateral sclerosis with ragged-red fibers.
[18332255] Arch Neurol 65(3): 403-6 (2008)
1995  
7
Amyotrophic lateral sclerosis.
[8580551] Intern Med 34(9): 824-32 (1995)
1995  
8
Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments.
[8592323] J Med Genet 32(11): 841-7 (1995)
2001  
9
Mechanisms of neurodegeneration in amyotrophic lateral sclerosis.
[11724913] Mol Pathol 54(6): 386-92 (2001)
2009  
10
Amyotrophic lateral sclerosis.
[19192301] Orphanet J Rare Dis 4(): 3 (2009)
2006  
11
Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T.
[16641339] Radiology 239(3): 831-8 (2006)
2011  
12
The microglial-motoneuron dialogue in ALS.
[21842586] Acta Myol 30(1): 4-8 (2011)
2008  
13
TAR DNA-binding protein-43 in amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and Alzheimer disease.
[18575875] Acta Neuropathol 116(2): 135-40 (2008)
2010  
14
The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy.
[19651206] Biochim Biophys Acta 1802(1): 186-97 (2010)
2010  
15
Mitochondrial dysfunction in amyotrophic lateral sclerosis.
[19715760] Biochim Biophys Acta 1802(1): 45-51 (2010)
2011  
16
Genetic rodent models of amyotrophic lateral sclerosis.
[21274268] J Biomed Biotechnol 2011(-): 348765 (2011)
2010  
17
Novel etiological and therapeutic strategies for neurodiseases: RNA editing enzyme abnormality in sporadic amyotrophic lateral sclerosis.
[20424386] J Pharmacol Sci 113(1): 9-13 (2010)
2002  
18
2010  
19
Motor neurone disease: clinical features, diagnosis, diagnostic pitfalls and prognostic markers.
[20593140] Singapore Med J 51(5): 367-72; quiz 373 (2010)
2005  
20
Management of patients with amyotrophic lateral sclerosis.
[16380848] Swiss Med Wkly 135(41-42): 626-9 (2005)
2010  
21
Protein disulfide isomerase and the endoplasmic reticulum in amyotrophic lateral sclerosis.
[20237255] J Neurosci 30(11): 3865-7 (2010)
2010  
22
Possible involvement of overexposure to environmental selenium in the etiology of amyotrophic lateral sclerosis: a short review.
[20847461] Ann Ist Super Sanita 46(3): 279-83 (2010)
2010  
23
TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.
[20400460] Hum Mol Genet 19(R1): R46-64 (2010)
2007  
24
Genetics of sporadic amyotrophic lateral sclerosis.
[17911166] Hum Mol Genet 16 Spec No. 2(-): R233-42 (2007)
2009  
25
Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis.
[19808791] Hum Mol Genet 18(R2): R156-62 (2009)
2010  
26
Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes.
[20880509] Neurotherapeutics 7(4): 471-81 (2010)
2010  
27
Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis.
[19903735] Brain 133(Pt 1): 105-16 (2010)
2007  
28
Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis.
[17716997] Brain 130(Pt 12): 3111-23 (2007)
2009  
29
In vivo morphological changes in animal models of amyotrophic lateral sclerosis and Alzheimer's-like disease: MRI approach.
[19943341] Anat Rec (Hoboken) 292(12): 1882-92 (2009)
2007  
30
Alsin and the molecular pathways of amyotrophic lateral sclerosis.
[17955197] Mol Neurobiol 36(3): 224-31 (2007)
2011  
31
TDP-43 in aging and Alzheimer's disease - a review.
[21326809] Int J Clin Exp Pathol 4(2): 147-55 (2011)
2008  
32
Targeting angiogenin in therapy of amyotropic lateral sclerosis.
[18781822] Expert Opin Ther Targets 12(10): 1229-42 (2008)
2008  
33
Strategic approaches to developing drug treatments for ALS.
[18190866] Drug Discov Today 13(1-2): 67-72 (2008)
2008  
34
ALS and FTLD: two faces of TDP-43 proteinopathy.
[18684309] Eur J Neurol 15(8): 772-80 (2008)
2011  
35
Brief review of the role of glycogen synthase kinase-3β in amyotrophic lateral sclerosis.
[21603026] Neurol Res Int 2011(-): 205761 (2011)
2011  
36
SOD1 Transcriptional and Posttranscriptional Regulation and Its Potential Implications in ALS.
[21603028] Neurol Res Int 2011(-): 458427 (2011)
2011  
37
Glial cells in amyotrophic lateral sclerosis.
[21766027] Neurol Res Int 2011(-): 718987 (2011)
2010  
38
Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies.
[20102519] Neuropathology 30(2): 103-12 (2010)
2008  
39
The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
[18989115] Curr Opin Neurol 21(6): 693-700 (2008)
2009  
40
Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases.
[19271105] J Neurol 256(8): 1205-14 (2009)
2009  
41
The genetics of amyotrophic lateral sclerosis.
[20054757] Neurol Neurochir Pol 43(6): 538-49 (2009)
2007  
42
Cargos and genes: insights into vesicular transport from inherited human disease.
[17526798] J Med Genet 44(9): 545-55 (2007)
2010  
43
State of the art and the dark side of amyotrophic lateral sclerosis.
[21540991] World J Biol Chem 1(5): 62-8 (2010)
2011  
44
The Role of immune and inflammatory mechanisms in ALS.
[21375489] Curr Mol Med 11(3): 246-54 (2011)
2010  
45
Mitochondrial dysfunction and intracellular calcium dysregulation in ALS.
[20493207] Mech Ageing Dev 131(7-8): 517-26 (2010)
2011  
46
Introducing Amyotrophic lateral sclerosis.
[21412712] Arch Ital Biol 149(1): 1-4 (2011)
2011  
47
The diagnosis of Amyotrophic lateral sclerosis in 2010.
[21412713] Arch Ital Biol 149(1): 5-27 (2011)
2011  
48
ALS, what new 144 years after Charcot?
[21412714] Arch Ital Biol 149(1): 29-37 (2011)
2011  
49
Clinical neurophysiology in ALS.
[21412716] Arch Ital Biol 149(1): 57-63 (2011)
2011  
50
Genetics of familial Amyotrophic lateral sclerosis.
[21412717] Arch Ital Biol 149(1): 65-82 (2011)
2011  
51
RNA-binding proteins and RNA metabolism: a new scenario in the pathogenesis of Amyotrophic lateral sclerosis.
[21412718] Arch Ital Biol 149(1): 83-99 (2011)
2011  
52
Mitochondrial disfunction as a cause of ALS.
[21412720] Arch Ital Biol 149(1): 113-9 (2011)
2011  
53
Protein clearing pathways in ALS.
[21412721] Arch Ital Biol 149(1): 121-49 (2011)
2011  
54
Strategies for clinical approach to neurodegeneration in Amyotrophic lateral sclerosis.
[21412722] Arch Ital Biol 149(1): 151-67 (2011)
2010  
55
The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis.
[22069578] Toxins (Basel) 2(12): 2837-50 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


  • Amyotrophe Lateralsklerose (Motoneuronerkrankung)


  • Search PubMed and many other databases on the combined search terms

    GG: als
    GG: amyotrophic lateral sclerosis

  • Amyotrophe Lateralsklerose

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia